425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. announced a proposed business combination, with Strive's CEO Matthew Cole sharing details on X.com.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was posted on X.com by Matthew Cole, Chief Executive Officer of Strive, Inc., on September 23, 2025.
• The filing primarily consists of cautionary statements regarding forward-looking information related to the proposed transaction.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, to register Class A common stock to be issued in the transaction.
• Stockholders of Semler Scientific will be asked to approve the proposed transaction.

Sentiment

Score: 5

Explanation: The filing announces a proposed business combination, which typically carries strategic benefits. However, the document is heavily focused on cautionary statements and a comprehensive list of risks associated with the transaction and forward-looking statements, balancing the overall sentiment to neutral.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are projected from the business combination.

Negatives

• Dilution is expected for existing shareholders due to Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships may occur.
• Changes in Strive's or Semler Scientific's share price before closing could negatively impact the transaction.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific.
• The proposed transaction may not close when expected or at all if conditions to closing are not met.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks are associated with Bitcoin and other digital assets, including those arising from Strive's Bitcoin treasury strategies.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the transaction process.

Future Outlook

The outlook and expectations of Strive and Semler Scientific are focused on the proposed business combination, including its strategic and financial benefits, the timing of its closing, and the successful integration of the combined businesses. The companies anticipate realizing cost savings and strategic gains.

Management Comments

• The communication was posted on X.com by Matthew Cole, Chief Executive Officer of Strive, Inc., in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

Strive's mention of 'Bitcoin treasury strategies' indicates its involvement or interest in digital assets, aligning with a growing trend of companies exploring or adopting cryptocurrency-related financial strategies. Semler Scientific, as a 'scientific' company, suggests a potential diversification or strategic alignment through this merger, possibly integrating digital asset strategies into a broader business model.

Stakeholder Impact

• Shareholders: Potential dilution due to the issuance of additional Class A common stock by Strive.
• Customers: Potential adverse reactions or changes to business relationships.
• Employees: Potential adverse reactions or changes to employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance, Stockholder Approval